WATSON 491 150 mg (Mexiletine hydrochloride 150 mg)

Pill imprint WATSON 491 150 mg has been identified as Mexiletine hydrochloride 150 mg.

Mexiletine is used in the treatment of myotonia congenita; ventricular tachycardia; diabetic peripheral neuropathy; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 491 150 mg

Mexiletine hydrochloride
Imprint:
WATSON 491
150 mg
Strength:
150 mg
Color:
Brown
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)